Keyphrases
Diabetes
100%
Therapeutic Use
100%
Metformin
100%
Clinical Course
100%
COVID-19
100%
COVID-19 Outcomes
100%
Clinical Outcomes
20%
Metformin Treatment
20%
PubMed Search
20%
Coronavirus
20%
Coronavirus Disease (COVID)
20%
COVID-19 Infection
20%
Cell Surface
10%
Beneficial Effects
10%
Insulin Resistance
10%
Type 2 Diabetic Patients
10%
Controlled Experiment
10%
Cardiovascular Risk
10%
Metabolic Effects
10%
Randomized Controlled Trial
10%
Clinical Trials
10%
Meta-analysis
10%
Intensive Care
10%
Retrospective Analysis
10%
Pleiotropic Effects
10%
Kinase Cascade
10%
Clinical Effect
10%
Clinical Literature
10%
Systemic Inflammation
10%
Hospitalization
10%
Acidosis
10%
Lactic Acidosis
10%
Reduced Mortality
10%
Hypercoagulability
10%
Adverse Prognosis
10%
Severe COVID-19
10%
Binding Targets
10%
Acute Renal Failure
10%
Key Binding
10%
Low Background
10%
Hypoxemia
10%
AMP Kinase
10%
ACE2 Protein
10%
COVID-19 Disease
10%
SARS-CoV-2 Spike Protein
10%
Medicine and Dentistry
Diabetes
100%
Drug Therapy
100%
Glycon
100%
Disease Course
100%
Infection
16%
Coronavirinae
16%
Severe Acute Respiratory Syndrome
16%
Disease
8%
Clinical Study
8%
Clinical Trial
8%
Maturity Onset Diabetes of the Young
8%
Prospective Study
8%
Insulin Resistance
8%
Cardiovascular Risk
8%
Randomized Controlled Trial
8%
Cell Surface
8%
Meta-Analysis
8%
Controlled Clinical Trial
8%
Systematic Review
8%
Intensive Care
8%
Phosphotransferase
8%
Observational Study
8%
Acidosis
8%
Nephropathy
8%
Lactic Acidosis
8%
Adenosine Phosphate
8%
Hypercoagulability
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Systemic Resistance
8%
Hypoxemia
8%
Pharmacology, Toxicology and Pharmaceutical Science
Therapeutic Use
100%
Metformin
100%
Disease Course
100%
Infection
16%
Severe Acute Respiratory Syndrome
16%
Coronavirinae
16%
Disease
8%
Phosphotransferase
8%
Inflammation
8%
Insulin Resistance
8%
Prospective Study
8%
Cardiovascular Risk
8%
Clinical Trial
8%
Randomized Controlled Trial
8%
Clinical Study
8%
Observational Study
8%
Kidney Disease
8%
Lactic Acidosis
8%
Adenosine Phosphate
8%
Controlled Clinical Trial
8%
Hypercoagulability
8%
SARS Coronavirus
8%
Hypoxemia
8%
Non Insulin Dependent Diabetes Mellitus
8%